Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mid-America Transplant is a U.S. nonprofit organ procurement and tissue recovery organization headquartered in St. Louis, Missouri. The organization coordinates organ, eye, and tissue donation, manages donor evaluation and recovery, supports transplant logistics, and works with hospitals, transplant centers, coroners, and medical examiners across its designated service area. It operates dedicated donor recovery infrastructure including operating rooms, a donor care unit, laboratories, eye bank and tissue offices, and also provides community-facing services such as donor-family support and transplant housing through its Family House program. Mid-America Transplant is healthcare-related, but it is not a drug-development biotech or pharma company; its core business is donation, recovery, transplantation support, and clinical innovation in transplant medicine. The organization also participates in clinical research intended to improve donor management, transplant safety, and organ utilization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mid-America Transplant.